August 8th, 2016: Understanding and Remembrance Day for Severe Myalgic Encephalomyelitis
Jody Smith joins with other ME voices in honor of Understanding and Remembrance Day for Severe Myalgic Encephalomyelitis.
Discuss the article on the Forums.

Increasing openness in clinical trials

Discussion in 'Other Health News and Research' started by MeSci, Jan 16, 2015.

  1. MeSci

    MeSci ME/CFS since 1995; activity level 6?

    Cornwall, UK
    From Physician's First Watch.

    I was particularly struck by this phrase:
    Although a clinical trial may help some participants gain remission from their illnesses, the main beneficiaries are the drug companies. The trials (if successful) enable the drug companies to gain a licence to market their drugs.

    OTOH, the patients who take such risks may not be able to continue taking the drugs because they cannot get funding to do so, especially if, as sometimes appears to happen, the drug companies put up the price once the licence has been obtained.
    JaimeS and Woolie like this.

See more popular forum discussions.

Share This Page